comparemela.com

Latest Breaking News On - Medication management solutions - Page 2 : comparemela.com

BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results

Execution of BD 2025 Strategy Driving Durable, Broad-Based Growth Q4 revenue of $5.1 billion increased 6.8% as reported and 5.9% on a currency-neutral basis Q4.

China
Russia
Ukraine
United-states
America
Troy-kirkpatrick
Transjugular-intrahepatic-portosystemic
Tom-polen
Embecta-corp
Revenue-growth
Bd-life-sciences-revenues
Bd-life-sciences

Becton, Dickinson and Company (NYSE:BDX) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to BD’s Third Fiscal Quarter of 2023 Earnings Call. At the request of BD, today’s call is being recorded.

China
Sweden
United-states
Australia
Denmark
New-zealand
Netherlands
India
Chris-delorefice
Larry-biegelsen
Patrick-wood
Francesca-demartino

BD Reports Third Quarter Fiscal 2023 Financial Results

Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™.

Ukraine
United-states
Russia
Dublin
Ireland
China
Troy-kirkpatrick
Francesca-demartino
Tom-polen
Companies-to-work
Business-revenue-growth-including-divested
Exchange-commission

vimarsana © 2020. All Rights Reserved.